isoniazid has been researched along with ferric citrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castilho, RF; Hermes-Lima, M; Meinicke, AR; Santos, NC | 1 |
| Alonso, A; Gomes, CS; Hermes-Lima, M; Lopes, GK; Maurício, AQ; Oliveira, RG | 1 |
2 other study(ies) available for isoniazid and ferric citrate
| Article | Year |
|---|---|
The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
Topics: Animals; Antioxidants; Chelating Agents; Ferric Compounds; In Vitro Techniques; Indicators and Reagents; Iron; Iron Chelating Agents; Isoniazid; Lipid Peroxidation; Membrane Potentials; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Pyridoxal; Rats; Thiobarbituric Acid Reactive Substances | 2001 |
Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.
Topics: Ascorbic Acid; Chelating Agents; Deoxyribose; Edetic Acid; Electron Spin Resonance Spectroscopy; Ferric Compounds; Free Radicals; Hydroxyl Radical; Isoniazid; Nitrilotriacetic Acid; Oxidation-Reduction; Oxidative Stress; Pyridoxal | 2003 |